← My Government dashboard

Government Watch

Dossier Legislative introduced 09-jul-2026
Bill introduced in Congress — not yet passed by either chamber, and not law.

Getting Innovations to Patients During Shutdowns Act

Key claim: HR9635, the Getting Innovations to Patients During Shutdowns Act, would ensure patients can continue to receive medical innovations during federal government shutdowns.

Abstract

(HR9635 · 119th Congress) Latest action (2026-07-09): Referred to the House Committee on Energy and Commerce.

Why this matters

Federal shutdowns can disrupt FDA review activities and delay patient access to new therapies, devices, and clinical trial approvals. HR9635 proposes to preserve continuity of these regulatory functions during lapses in appropriations, addressing an operational gap that has repeatedly affected drug approvals and trial enrollment. The bill is at an early stage (introduced, referred to committee).

Source

Link

Briefing card

Getting Innovations to Patients During Shutdowns Act
Stage: introduced · congress · 09-jul-2026

HR9635, the Getting Innovations to Patients During Shutdowns Act, would ensure patients can continue to receive medical innovations during federal government shutdowns.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: congress:119-hr-9635:introduced

Ask about this finding

Replies are grounded in the abstract and metadata above. The model will quote directly when possible and say so if a question isn't covered.

Stages other doctrine resolution introduced proposed rule passed chamber executive action final rule enacted district opinion circuit opinion opinion

Subscribe: calendar of upcoming dates · deadlines feed · all new records

build build 392 · ea9c128-dirty · 2026-08-09